Improvement plan for Domestic biosimilar drug assessment to be finalized
As the government included the biopharmaceutical industry in the target for the relaxation policy of regulation, the Ministry of Health and Welfare(MOHW) is planning to finalize the improvement plan for drug price assessment of biosimilars soon.
Based on the government’s relaxation policy of reg...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
